Research
All
staff are engaged in research as well as in teaching and hospital work.
The pattern of disease in Hong Kong is now similar to that in the West,
although certain diseases e.g. hepatocellular and nasopharyngeal carcinoma
are much commoner here. The research interests of staff are focused mainly
on oncology and, on a divisional basis, include:
Anatomical Pathology
Studies of molecular genetics in various types of cancer, e.g., breast, liver, lung, colon; tumour angiogenesis, cytokines and tumour-associated macrophages in cancer; genetics of hereditary renal diseases; molecular genetic studies on gestational trophoblastic disease; cytogenetic study of tumours by chromosome ISH; oncogenic viruses in tumours of the lymphoreticular system, liver and nasopharynx, etc.
Haematology
Molecular genetics of leukaemia, thalassaemia and coagulation; epidemiology of childhood leukaemia; cytogenetic and molecular study of haematological malignancies; thrombophilia; haemopoiesis, etc.
Immunology
B cell origins and development; follicular dendritic cells and prions; comparative immunology
State Key Laboratory for Liver Research (HKU)
The State Key Laboratory for Liver Research (SKLLR) was set up and approved by the Ministry of Science Technology of China in the summer of 2010. The SKLLR aims to enhance our understanding in the pathogenetic mechanisms of HBV, cirrhosis and liver cancer by engaging in cutting-edge basic research, and develop better diagnosis and new/better treatment modalities for HBV infection and liver cancer. The SKLLR brings together researchers from different specialties and with various expertise. This SKLLR will lead new research and treatment directions in liver diseases and nurture a new generation of scientists and clinicians in this field.